Patients who are taking concomitant diabetes medications should monitor their blood sugars closely and be prepared to treat hypoglycemia (see hypoglycemia for more) Injection site reactions Injection site reactions, including pruritus, erythema, inflammation, induration, and irritation, may occur
Studies, such as those published in Cell Metabolism, suggest that GLP-1 can dampen this reward response, making these foods seem less appealing and reducing cravings
Genetic variation in receptor density, body composition, metabolic rate, and prior medication history all influence the starting dose experience
These are usually mild and tend to improve during the first week or two as your body adjusts